ECSP003527A - Antagonistas del receptor de il - 8 v - Google Patents
Antagonistas del receptor de il - 8 vInfo
- Publication number
- ECSP003527A ECSP003527A EC2000003527A ECSP003527A ECSP003527A EC SP003527 A ECSP003527 A EC SP003527A EC 2000003527 A EC2000003527 A EC 2000003527A EC SP003527 A ECSP003527 A EC SP003527A EC SP003527 A ECSP003527 A EC SP003527A
- Authority
- EC
- Ecuador
- Prior art keywords
- receiver antagonists
- antagonists
- receiver
- chemokine
- interleukin
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 102000004890 Interleukin-8 Human genes 0.000 abstract 2
- 108090001007 Interleukin-8 Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Esta invención se refiere a nuevos compuestos de la fórmula (I), y a composiciones de los mismos, útiles en el tratamiento de enfermedades mediadas por la quimioquina interleuquina-8(IL-8)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13967799P | 1999-06-16 | 1999-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003527A true ECSP003527A (es) | 2002-01-25 |
Family
ID=22487800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2000003527A ECSP003527A (es) | 1999-06-16 | 2000-06-14 | Antagonistas del receptor de il - 8 v |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1185270A4 (es) |
JP (1) | JP2003501472A (es) |
AU (1) | AU5748300A (es) |
CO (1) | CO5190712A1 (es) |
EC (1) | ECSP003527A (es) |
HK (1) | HK1044475A1 (es) |
PE (1) | PE20010321A1 (es) |
UY (1) | UY26207A1 (es) |
WO (1) | WO2000076517A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6642215B2 (en) * | 2001-05-24 | 2003-11-04 | Leo Pharma A/S | Method of modulating NF-kB activity |
JP2007537272A (ja) | 2004-05-12 | 2007-12-20 | シェーリング コーポレイション | Cxcr1およびcxcr2ケモカインアンタゴニスト |
EP3355876A2 (en) * | 2015-09-30 | 2018-08-08 | Instituto de Medicina Molecular | Methods for attenuating parasite virulence |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2928485A1 (de) * | 1979-07-14 | 1981-01-29 | Bayer Ag | Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen |
JPH0678298B2 (ja) * | 1988-03-30 | 1994-10-05 | ワーナー‐ランバート・コンパニー | N‐〔〔(2,6‐ジ置換)フエニル〕‐n′‐アリールアルキル〕尿素 |
US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
JP2000516621A (ja) * | 1996-08-15 | 2000-12-12 | スミスクライン・ビーチャム・コーポレイション | Il―8レセプターアンタゴニスト |
-
2000
- 2000-06-14 CO CO00044229A patent/CO5190712A1/es unknown
- 2000-06-14 PE PE2000000591A patent/PE20010321A1/es not_active Application Discontinuation
- 2000-06-14 EC EC2000003527A patent/ECSP003527A/es unknown
- 2000-06-14 UY UY26207A patent/UY26207A1/es not_active Application Discontinuation
- 2000-06-16 EP EP00942934A patent/EP1185270A4/en not_active Withdrawn
- 2000-06-16 WO PCT/US2000/016814 patent/WO2000076517A1/en not_active Application Discontinuation
- 2000-06-16 JP JP2001502850A patent/JP2003501472A/ja not_active Withdrawn
- 2000-06-16 AU AU57483/00A patent/AU5748300A/en not_active Abandoned
-
2002
- 2002-08-21 HK HK02106146.8A patent/HK1044475A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1185270A1 (en) | 2002-03-13 |
JP2003501472A (ja) | 2003-01-14 |
EP1185270A4 (en) | 2004-02-11 |
HK1044475A1 (zh) | 2002-10-25 |
AU5748300A (en) | 2001-01-02 |
UY26207A1 (es) | 2000-12-29 |
PE20010321A1 (es) | 2001-05-18 |
CO5190712A1 (es) | 2002-08-29 |
WO2000076517A1 (en) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0313109A (pt) | Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como ligandos de receptor de quimiocina de cxc | |
CY1106514T1 (el) | Ανταγωνιστες υποδοχεων il-8 | |
EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
CR10391A (es) | Antagonistas del receptor de la il-8. | |
CR8475A (es) | Fenilalanina-amidas sustituidas por benzoilo | |
ATE419845T1 (de) | Il-8-rezeptor-antagonisten | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
ECSP066474A (es) | Arilindenopiridinas y arilindenopirimidinas y su uso como antagonista del receptor adenosina a2a | |
PA8579601A1 (es) | Compuestos antiinflamatorios de di y trifloruro-triazolo-piridinas | |
UY26601A1 (es) | Antagonistas de los receptores de il-8 | |
ATE365730T1 (de) | Neuartige verbindungen | |
AR024350A1 (es) | Antagonistas de los receptores de il-8 | |
MY128154A (en) | Il-8 receptor antagonists | |
ECSP003527A (es) | Antagonistas del receptor de il - 8 v | |
MY143477A (en) | Il-8 receptor antagonists | |
BR0010843A (pt) | Antagonistas de receptores de il-8 | |
AP2002002606A0 (en) | INTERLEUKIN 8 RECEPTOR ANTAGONISTS | |
ECSP003529A (es) | Antagonistas del receptor de il - 8 vii | |
UY26209A1 (es) | Antagonistas de los receptores de la il-8. | |
BR0010863A (pt) | Antagonistas de receptores de il-8 | |
WO2001068033A3 (en) | Il-8 receptor antagonists | |
BR9815951A (pt) | Antagonistas do receptor de il-8 | |
UY26206A1 (es) | Antagonistas del receptor de il-8. | |
PE20001466A1 (es) | Nuevas 3-fenoxi- y 3-fenilalquiloxi-2-fenil-propilaminas sustituidas como bloqueadores del canal de sodio |